The changing pattern of infection in neutropenic patients

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue SUPPL. D, 1998, Pages 7-11

  Oppenheim, Beryl A ^a  

^a WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HUMAN; NEUTROPENIA; SHORT SURVEY;

ANTINEOPLASTIC AGENTS; COAGULASE; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; NEOPLASMS; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; RISK; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0031778256     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.suppl_4.7     Document Type: Short Survey

References (44)

1. Bodey, G. P. (1975). Infections in cancer patients. Cancer Treatment Reviews 2, 89-128.
2. EORTC International Antimicrobial Therapy Cooperative Group. (1990). Gram-positive bacteraemia in granulocytopenic cancer patients. European Journal of Cancer 26, 569-74.
3. EORTC Antimicrobial Therapy Project Group. (1978). Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases 137, 14-29.
4. EORTC International Antimicrobial Therapy Project Group. (1983). Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. Journal of Clinical Oncology 1, 597-603.
5. Klastersky, J., Glauser, M. P., Schimpff, S. C., Zinner, S. H. & Gaya, H. (1986). Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrobial Agents and Chemotherapy 29, 263-70.
6. EORTC International Antimicrobial Therapy Cooperative Group. (1987). Ceftazidime combined with a short or long course of amikacin for empirical therapy of Gram-negative bacteremia in cancer patients with granulocytopenia. New England Journal of Medicine 317, 1692-8.
7. EORTC International Antimicrobial Therapy Cooperative Group. (1993). Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Annals of Internal Medicine 119, 584-93.
8. Cometta, A., Zinner, S., de Bock, R., Calandra, T., Gaya, H., Klatersky, J. et al. (1995). Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrobial Agents and Chemotherapy 39, 445-52.
9. Cometta, A., Calandra, T., Gaya, H., Zinner, S. H., de Bock, R., del Favero, A. et al. (1996). Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrobial Agents and Chemotherapy 40, 1108-15.
10. Flanagan, N. G., Kelsey, P. R., Whitson, A., Flores, B., Lewis, D. R. & Randall, M. (1994). Infection in immunocompromised patients with malignant blood disorders in a district general hospital. Journal of Infection 29, 195-202.
11. Bender, J. W. & Hughes, W. T. (1980). Fatal Staphylococcus epidermidis sepsis following bone marrow transplantation. Johns Hopkins Medical Journal 146, 13-5.
12. Wade, J. C., Schimpff, S. C., Newman, K. A. & Wiernik, P. H. (1982). Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Annals of Internal Medicine 97, 503-8.
13. Pittet, D. & Wenzel, R. P. (1995). Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Archives of Internal Medicine 155, 1177-84.
14. Herwaldt, L. A., Hollis, R. J., Boyken, L. D. & Pfaller, M A. (1992). Molecular epidemiology of coagulase-negative staphylococci isolated from immunocompromised patients. Infection Control and Hospital Epidemiology 13, 86-92.
15. Pfaller, M. A. & Herwaldt, L. A. (1988). Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clinical Microbiology Reviews 1, 281-99.
16. Van den Broek, P. J., Lampe, A. S., Berbee, G. A. M., Thompson, J. & Mouton, R. P. (1985). Epidemic of prosthetic valve endocarditis caused by Staphylococcus epidermidis. British Medical Journal 291, 949-50.
17. Houang, E. T., Marples, R. R., Weir, I., Mourant, A. J., de Saxe, M. J. & Singleton, B. (1986). Problems in the investigation of an apparent outbreak of coagulase-negative staphylococcal septicaemia following cardiac surgery. Journal of Hospital Infection 8, 224-32.
18. Oppenheim, B. A., Hartley, J. W., Lee, W. & Burnie, J. P. (1989). Outbreak of coagulase negative Staphylococcus highly resistant to ciprofloxacin in a leukaemia unit. British Medical Journal 299, 294-7.
19. Goldstein, F. W., Coutrot, A., Sieffer, A. & Acar, J. F. (1990). Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrobial Agents and Chemotherapy 34, 899-900.
20. Maugein, J., Pellegrin, J. L., Brossard, G., Fourche, J., Leng, B. & Reiffers J. (1990). In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients. Antimicrobial Agents and Chemotherapy 34, 901-3.
21. Hoecker, J. L., Pickering, L. K., Groschel, D. & Kohl, S. (1978). Streptococcus salivarius sepsis in children with malignancies. Journal of Pediatrics 92, 337-8.
22. Pizzo, P. A., Ladisch, S. & Witebsky, F. G. (1978). Alpha-hemolytic streptococci: clinical significance in the cancer patient. Medical and Pediatric Oncology 4, 367-70.
23. Burden, A. D., Oppenheim, B. A., Crowther, D., Howell, A., Morgenstern, G. R., Scarffe, J. H. et al. (1991). Viridans streptococcal bacteraemia in patients with haematological and solid malignancies. European Journal of Cancer 27, 409-11.
24. Richard, P., Amador Del Valle, G., Moreau, P., Milpied, N., Felice, M.-P., Daeschler, T. et al. (1995). Viridans streptococcal bacteraemia in patients with neutropenia. Lancet 345, 1607-9.
25. Weisman, S. J., Scoopo, F. J., Johnson, G. M., Altman, A. J. & Quinn, J. J. (1990). Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. Journal of Clinical Oncology 6, 453-9.
26. Bochud, P.-Y., Calandra, T. & Francioli, P. (1994). Bacteremia due to viridans streptococci in neutropenic patients: a review. American Journal of Medicine 97, 256-64.
27. Henslee, J., Bostrom, B., Weisdorf, D., Ramsay, N., McGlave, P. & Kersey, J. (1984). Streptococcal sepsis in bone marrow transplant patients. Lancet i, 393.
28. Elting, L. S., Bodey, G. P. & Keefe, B. H. (1992). Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clinical Infectious Diseases 14, 1201-7.
29. Beighton, D., Hardie, J. M. & Whiley, R. A. (1991). A scheme for the identification of viridans streptococci. Journal of Medical Microbiology 35, 367-72.
30. Beighton, D., Carr, A. D. & Oppenheim, B. A. (1994). Identification of viridans streptococci associated with bacteraemia in neutropenic cancer patients. Journal of Medical Microbiology 40, 202-4.
31. Schaberg, D. R., Culver, D. H. & Gaynes, R. P. (1991). Major trends in the microbial etiology of nosocomial infection. American Journal of Medicine 91, Suppl. B, 72S-5S.
32. Moellering, R. C. (1995). Epidemiology and the clinical impact of glycopeptide resistance in enterococci. In Abstracts of the 7th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, 1995. Abstract 557, p. 107. European Society of Clinical Microbiology and Infectious Diseases.
33. Arthur, M. & Courvalin, P. (1993). Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrobial Agents and Chemotherapy 37, 1563-71.
34. Montecalvo, M. A., Horowitz, H., Gedris, C., Carbonaro, C., Tenover, F. C., Issah, A. et al. (1994). Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrobial Agents and Chemotherapy 38, 1363-7.
35. Edmond, M. B., Ober, J. F., Weinbaum, D. L, Pfaller, M. A., Hwang, T., Sanford, D. et al. (1995). Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clinical Infectious Diseases 20, 1126-33.
36. Livornese, L. L., Dias, S., Samel, C., Romanowski, B., Taylor, S., May, P. et al. (1992). Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Annals of Internal Medicine 117, 112-6.
37. Orr, K. E., Gould, F. K., Perry, J. D., Ford, M., Morgan, S., Sisson, P. R. et al. (1994). Therapeutic beds: the Trojan horses of the 1990s? Lancet 344, 65-6.
38. Chadwick, P. R. & Oppenheim, B. A. (1994). Vancomycin-resistant enterococci and bedpan washer machines. Lancet 344, 685.
39. Noble, W. C., Virani, Z. & Cree, R. G. A. (1992). Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiology Letters 93, 195-8.
40. Hospital Infection Control Practices Advisory Committee (HICPAC). (1995). Recommendations for preventing the spread of vancomycin resistance. Infection Control and Hospital Epidemiology 16, 105-13.
41. Kern, W. V., Markus, A. & Andriof, E. (1994). Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients. European Journal of Clinical Microbiology & Infectious Diseases 13, 161-5.
42. Cometta, A., Calandra, T., Bille, J. & Glauser, M. P. (1994). Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. New England Journal of Medicine 330, 1240-1.
43. Kern, W. V., Andriof, E., Oethinger, M., Kern, P., Hacker, J. & Marre, R. (1994). Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrobial Agents and Chemotherapy 38, 681-7.
44. Peña, C., Albareda, J. M., Pallares, R., Pujol, M., Tubau, F. & Ariza, J. (1995). Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrobial Agents and Chemotherapy 39, 520-4.